I'm not quite sure of why so many are seemingly concerned about IP theft.
The risks today are no greater than they were the day we launched Novosorb... and the risks to Polynovo are no different to the risks of every other innovative company in the world... and not just related to China.
The manufacturing process is a combination of IP and trade secret. It is not so easy to reverse engineer it.
As I've noted previously, I don't imagine we would ever manufacture in China. We would supply from other facilities and therefore nothing changes other than the massive additional sales.
I remain excited by the prospect of something big happening in the Chinese market.
No stress on my part regarding our IP.
Fes
Ann: Hong Kong - Two cases, Two surgeons, page-23
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10700 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 24502 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |